Ethambutol Tablets BP 200 mg Supplier in India – Healthy Inc

Ethambutol Tablets BP 200 mg | Supplier
Product image for Ethambutol Tablets BP 200 mg Supplier; wholesale & institutional bulk supply.
Product Information
| Generic Name | Ethambutol |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049053 |
| Pharmacopoeia | BP |
| Product Type | Tablet |
| Category | Antitubercular drugs |
| Subcategory | Antitubercular drugs |
| Active Ingredient | Ethambutol |
| Strength | 200 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antitubercular drugs |
Medicine Details & Safety
| Short Description | Healthy Inc invites B2B supply enquiries for Ethambutol Tablets BP 200 mg from licensed wholesalers, distributors, pharmacy procurement teams and institutional buyers. Order quantities, stock status, batch details and delivery schedules are confirmed before commercial acceptance. | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. First-line multidrug treatment of pulmonary and extrapulmonary tuberculosis. 2. Prophylaxis and latent tuberculosis infection management in high-risk individuals. | ||||||||||||||||||||||||||||||||||
| Full Description | Healthy Inc invites B2B supply enquiries for Ethambutol Tablets BP 200 mg from licensed wholesalers, distributors, pharmacy procurement teams and institutional buyers. Order quantities, stock status, batch details and delivery schedules are confirmed before commercial acceptance. Product technical specifications
Product technical specifications
Supply channels and buyer segmentsHospital procurement teams and institutional tender buyers can submit tender specifications, required documentation and staggered delivery schedules. Wholesalers and pharmacy chains can request pack configurations and replenishment planning. PCD distributors may submit territory and commercial requirements for review.Commercial supply matrix
Inventory and batch traceabilityRequest available batch numbers, expiry details, COA and approved storage conditions for Ethambutol Tablets BP 200 mg. Agree minimum remaining shelf life and stock rotation requirements before dispatch.Procurement and deliverySubmit purchase quantity, delivery location, buyer licence details and required documents. Confirm commercial terms, payment conditions, transport arrangements and repeat-order schedule. Stock and delivery are not guaranteed until confirmed. | ||||||||||||||||||||||||||||||||||
| Dosage Instructions | Administer orally as a single daily dose on an empty stomach (at least 30 minutes before meals or 2 hours after meals) with water. Ensure continuous daily administration under directly observed therapy protocols. | ||||||||||||||||||||||||||||||||||
| Side Effects | Common: Gastrointestinal distress, anorexia, nausea, orange-red discoloration of body fluids, mild transaminase rise. Uncommon: Peripheral neuropathy, arthralgia, headache, dizziness, cutaneous flushing. Rare: Drug-induced hepatotoxicity, optic neuritis, thrombocytopenia, hemolytic anemia. | ||||||||||||||||||||||||||||||||||
| Warnings and Precautions | Hepatic Function Surveillance: Baseline and monthly liver function tests are recommended; immediately discontinue if transaminases exceed 3-5 times normal. Neuropathy Prophylaxis: Co-administer pyridoxine (vitamin B6) in patients susceptible to peripheral neuritis. Adherence: Strict uninterrupted compliance is vital to prevent MDR-TB emergence. | ||||||||||||||||||||||||||||||||||
| Contraindications | 1. Hypersensitivity to Ethambutol or related hydrazide/rifamycin antimycobacterial drugs. 2. Severe acute liver disease or preexisting drug-induced hepatitis. 3. Severe peripheral neuropathy or preexisting optic neuritis (for ethambutol). | ||||||||||||||||||||||||||||||||||
| Drug Interactions | 1. Potent CYP Inducers/Substrates: Rifamycin derivatives accelerate hepatic metabolism of oral contraceptives, warfarin, and protease inhibitors. 2. Antacids: Aluminum hydroxide decreases antimycobacterial absorption; space dosing by 2 hours. 3. Hepatotoxic Drugs & Alcohol: Compounded risk of severe hepatic necrosis. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Who can request bulk supply for Ethambutol Tablets BP 200 mg? | Licensed pharmaceutical wholesalers, distributors and institutional procurement teams can submit enquiries. |
| What is the minimum order quantity for Ethambutol Tablets BP 200 mg? | MOQ is confirmed according to pack configuration and order requirements. |
| Is ready stock available for Ethambutol Tablets BP 200 mg? | Request current stock and batch availability before placing an order. |
| Can institutional tender requirements be supported for Ethambutol Tablets BP 200 mg? | Submit tender specifications and delivery schedule for feasibility review. |
| How can I request wholesale pricing for Ethambutol Tablets BP 200 mg? | Provide quantity, delivery location and required packaging for a quotation. |
Related Products
✚
Ethambutol Tablets BP 200 mg ExporterView product →
✚
Ethambutol Tablets BP 200 mg ManufacturerView product →
✚
Ethambutol Tablets BP 400 mg ExporterView product →
✚
Ethambutol Tablets BP 400 mg ManufacturerView product →
✚
Ethambutol Tablets BP 400 mg SupplierView product →
✚
Ethambutol Tablets BP 800 mg ExporterView product →
✚
Ethambutol Tablets BP 800 mg ManufacturerView product →
✚
Ethambutol Tablets BP 800 mg SupplierView product →
✚
Ethambutol Tablets IP 400 mg ExporterView product →
✚
Ethambutol Tablets IP 400 mg ManufacturerView product →
✚
Ethambutol Tablets IP 400 mg SupplierView product →
✚
Ethambutol Hydrochloride Tablets IP 200 mg ExporterView product →
